Air pollution and traffic linked to deaths and organ rejection in lung transplant patients

Researchers have shown for the first time that lung transplant patients in Europe who live on or near busy roads with high levels of air pollution are more likely to die or to experience chronic organ rejection, Continue reading Air pollution and traffic linked to deaths and organ rejection in lung transplant patients

Arno Therapeutics’ AR-13 Shows Promise as Potential New Cystic Fibrosis Therapeutic Option for Serious Bacterial Infections

http://cysticfibrosisnewstoday.com/2015/09/25/arno-therapeutics-ar-13-shows-promise-potential-new-cystic-fibrosis-therapeutic-option-serious-bacterial-infections/

First published by Cystic Fibrosis News Today
By Charles Moore

Flemington, New Jersey based clinical stage biopharmaceutical company Arno Therapeutics, Inc. has announced data from a preclinical study demonstrating that its drug candidate AR-13, an analogue of Arno’s AR-12 infectious disease Continue reading Arno Therapeutics’ AR-13 Shows Promise as Potential New Cystic Fibrosis Therapeutic Option for Serious Bacterial Infections